Recent news on Cbdca

Medical Management of Patients With Head and Neck Cancer  -  Mar 1, 2007
Medscape (subscription)Suntharalingam M, Taylor R, Wolf J, Cullen K, Zimrin A. Initial report of phase II trial of weekly cetuximab, CBDCA, paclitaxel and daily RT in patients

Cetuximab May Prolong Survival for Head and Neck Cancer Patients  -  18 Jan 2007
Newswise (press release)The abstract, “Initial Report of Phase II Trial of Weekly Cetuximab, CBDCA, Paclitaxel and Daily RT in Patients with Locally Advanced SCCHN,� will be

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional